Drug recall · April 16, 2025
Sofosbuvir and Velpatasvir recall
Why: Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1
- Lots / codes
Lot# 24ASV002UA, Exp Date: 6/30/2028
- Quantity
- 18,541 cartons.
- Company
- Asegua Therapeutics LLC, Foster City, CA
- Distribution
- US Nationwide
- Initiated
- March 7, 2025 · Voluntary: Firm initiated
- Classified
- April 7, 2025
- Reported
- April 16, 2025
- Ended
- September 29, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sofosbuvir / velpatasvir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.